Schedule 13G ownership disclosure

ABIVAX SA SPONSORED ADS

Ordinary shares, nominal value Euro 0.01 per share · CUSIP: 00370M103

Event date: 2022-09-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Invus Public Equities, L.P.

    Shares: 5,403,985 · Class: 8.5%

  • Invus Public Equities Advisors, LLC

    Shares: 5,403,985 · Class: 8.5%

  • Invus Global Management, LLC

    Shares: 5,403,985 · Class: 8.5%

  • Siren, L.L.C.

    Shares: 5,403,985 · Class: 8.5%

  • Raymond Debbane

    Shares: 5,403,985 · Class: 8.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-053321
Form type
SCHEDULE 13G
Filer
Abivax S.A.
CIK
CIK 1956827
Filed
Apr 11, 2025
Reporting period
Sep 02, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub